Search Results - "Espuny Miró, Alberto"
-
1
Carboplatin dosing in obese patients
Published in Journal of oncology pharmacy practice (04-11-2024)“…The study aimed to: 1) Describe the carboplatin dosing criteria in obese patients in routine clinical practicein a general university hospital. 2) Evaluate…”
Get full text
Journal Article -
2
Predictive biomarkers of response to immune checkpoint inhibitors
Published in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (01-07-2020)“…The present paper provides a literature review aimed at identifying the tumor-dependent factors capable of influencing a subject's response to immune…”
Get more information
Journal Article -
3
Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients
Published in International journal of clinical pharmacy (01-02-2017)“…Background The administration of triple intrathecal therapy with methotrexate, cytarabine and a corticosteroid for the prophylaxis and treatment of neoplastic…”
Get full text
Journal Article -
4
Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients
Published in International journal of clinical pharmacy (01-12-2014)“…Background Onco-hematological patients are particularly susceptible to drug–drug interactions (DDIs) because they often undergo multiple combined treatments…”
Get full text
Journal Article -
5
Practical aspects of the use of intrathecal chemotherapy
Published in Farmacia hospitalaria (01-01-2017)“…Intrathecal chemotherapy is frequently used in clinical practice for treatment and prevention of neoplastic meningitis. Despite its widespread use, there is…”
Get full text
Journal Article -
6
Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use
Published in Journal of oncology pharmacy practice (01-10-2016)“…Introduction Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system…”
Get full text
Journal Article -
7
Evaluation of standardized triple intrathecal therapy toxicity in oncohematological adult patients
Published in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (01-09-2017)“…To assess the toxicity of a standardized triple intrathecal chemotherapy in onco- hematological adult patients and to establish risk factors of toxicity…”
Get more information
Journal Article -
8
Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors
Published in International journal of clinical pharmacy (01-12-2015)“…Background Oncological patients are at high risk for drug–drug interactions (DDIs), which may contribute to therapeutic failure or lead to serious adverse…”
Get full text
Journal Article -
9
Cyclosporin-induced thrombotic thrombocytopenic purpura. Report of three cases
Published in Medicina clinica (04-03-2016)Get more information
Journal Article -
10
Potential drug–drug interactions in hospitalised haematological patients
Published in Journal of oncology pharmacy practice (01-09-2017)“…Background Frequently, haematological patients undergo highly complex and intensive treatment protocols, so a high risk of drug–drug interactions could be…”
Get full text
Journal Article -
11
Cyclosporin-induced thrombotic thrombocytopenic purpura. Report of three cases
Published in Medicina clínica (English ed.) (04-03-2016)Get full text
Journal Article